PPARG anticorps (pSer273)
-
- Antigène Voir toutes PPARG Anticorps
- PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))
-
Épitope
- pSer273
-
Reactivité
- Humain, Souris, Rat, Mouton, Cobaye
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PPARG est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Réactivité croisée
- Cobaye, Humain, Souris, Rat, Mouton
- Homologie
- Cow,Chicken,Rabbit
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic phosphopeptide derived from human PPAR Gamma around the phosphorylation site of ser273
- Isotype
- IgG
- Top Product
- Discover our top product PPARG Anticorps primaire
-
-
- Indications d'application
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Date de péremption
- 12 months
-
-
Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats." dans: Molecular and cellular endocrinology, Vol. 439, pp. 105-115, (2018) (PubMed).
: "Dihydromyricetin enhances glucose uptake by inhibition of MEK/ERK pathway and consequent down-regulation of phosphorylation of PPARγ in 3T3-L1 cells." dans: Journal of cellular and molecular medicine, Vol. 22, Issue 2, pp. 1247-1256, (2017) (PubMed).
: "Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice." dans: The Journal of biological chemistry, Vol. 291, Issue 6, pp. 2583-600, (2016) (PubMed).
: "Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome." dans: Scientific reports, Vol. 6, pp. 24392, (2016) (PubMed).
: "Peroxisome Proliferator-activated Receptor-γ Activation Augments the β-Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-obese Diabetic Mice." dans: The Journal of biological chemistry, Vol. 291, Issue 43, pp. 22524-22533, (2016) (PubMed).
: "Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 ..." dans: The Journal of biological chemistry, Vol. 291, Issue 47, pp. 24475-24486, (2016) (PubMed).
: "Identification of a novel selective agonist of PPAR? with no promotion of adipogenesis and less inhibition of osteoblastogenesis." dans: Scientific reports, Vol. 5, pp. 9530, (2015) (PubMed).
: "Partial agonist, telmisartan, maintains PPAR? serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass." dans: PLoS ONE, Vol. 9, Issue 5, pp. e96323, (2014) (PubMed).
: "Aspartame downregulates 3T3-L1 differentiation." dans: In vitro cellular & developmental biology. Animal, Vol. 50, Issue 9, pp. 851-7, (2014) (PubMed).
: "Low birth weight male guinea pig offspring display increased visceral adiposity in early adulthood." dans: PLoS ONE, Vol. 9, Issue 6, pp. e98433, (2014) (PubMed).
: "
-
Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats." dans: Molecular and cellular endocrinology, Vol. 439, pp. 105-115, (2018) (PubMed).
-
- Antigène
- PPARG (Peroxisome Proliferator-Activated Receptor gamma (PPARG))
- Autre désignation
- PPAR Gamma (PPARG Produits)
- Synonymes
- anticorps PPAR gamma, anticorps PPARg2, anticorps PPARG, anticorps Nr1c3, anticorps PPAR-gamma, anticorps PPAR-gamma2, anticorps PPARgamma, anticorps PPARgamma2, anticorps NR1C3, anticorps CIMT1, anticorps GLM1, anticorps PPARG1, anticorps PPARG2, anticorps xPPAR-gamma, anticorps PPAR-GAMMA, anticorps PPARGAMMA, anticorps peroxisome proliferator-activated receptor gamma, anticorps peroxisome proliferator activated receptor gamma, anticorps peroxisome proliferator activated receptor gamma L homeolog, anticorps PPARG, anticorps Pparg, anticorps pparg.L
- Sujet
-
Synonyms: GLM1, CIMT1, NR1C3, PPARG1, PPARG2, PPARgamma, Peroxisome proliferator-activated receptor gamma, PPAR-gamma, Nuclear receptor subfamily 1 group C member 3, PPARG
Background: Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated proinflammatory responses.
- ID gène
- 5468
- UniProt
- P37231
- Pathways
- Signalisation MAPK, Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, Regulation of Lipid Metabolism by PPARalpha, Positive Regulation of Endopeptidase Activity, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
-